[Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana]

Ann Dermatol Venereol. 2014 Jun-Jul;141(6-7):413-8. doi: 10.1016/j.annder.2014.01.010. Epub 2014 Feb 24.
[Article in French]

Abstract

Background: In recent years, first-line therapy for Mycobacterium ulcerans infection in French Guiana has consisted of antibiotics active against this organism. Two regimens are used comprising rifampicin associated with clarithromycin or amikacin.

Patients and methods: We describe four patients presenting apparent worsening of their lesions during treatment: ulceration of a nodular lesion in a 32-year-old woman and worsening of an ulcerated lesion in three patients aged 16, 27 and 79 years.

Discussion: In these 4 patients, we concluded that the symptoms were caused by a paradoxical response or a reaction, a phenomenon already described in tuberculosis and leprosy. Such worsening is transient and must not be misinterpreted as failure to respond to treatment. The most plausible pathophysiological hypothesis involves the re-emergence of potentially necrotizing cellular immunity secondary to the loss of mycolactone, a necrotizing and immunosuppressive toxin produced by M. ulcerans, resulting from the action of the antibiotics.

Keywords: Buruli ulcer; French Guiana; Guyane française; Maladie tropicale; Mycobacterium ulcerans; Paradoxical reaction; Réaction paradoxale; Tropical disease; Ulcère de Buruli.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amikacin / administration & dosage
  • Amikacin / adverse effects*
  • Amikacin / pharmacology
  • Amikacin / therapeutic use
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Asia / ethnology
  • Brazil / ethnology
  • Buruli Ulcer / drug therapy*
  • Buruli Ulcer / pathology
  • Buruli Ulcer / surgery
  • Clarithromycin / administration & dosage
  • Clarithromycin / adverse effects*
  • Clarithromycin / pharmacology
  • Clarithromycin / therapeutic use
  • Combined Modality Therapy
  • Debridement
  • Drug Therapy, Combination
  • Europe / ethnology
  • Female
  • Foot Ulcer / drug therapy
  • Foot Ulcer / etiology
  • Foot Ulcer / surgery
  • French Guiana
  • Humans
  • Immunity, Cellular / drug effects
  • Macrolides / metabolism
  • Male
  • Mycobacterium ulcerans / drug effects
  • Mycobacterium ulcerans / metabolism
  • Rifampin / administration & dosage
  • Rifampin / adverse effects*
  • Rifampin / pharmacology
  • Rifampin / therapeutic use
  • Wound Healing

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • mycolactone
  • Amikacin
  • Clarithromycin
  • Rifampin